glp-1 and gip for weight loss V2 GLP-1 Therapy Part 1: Setting

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA

In occupational health settings , whilst disclosure is not mandatory for drug testing purposes, employees in safety-critical roles should consider informing occupational health physicians about any medication that might affect their ability to perform duties safely

Tajiri J, Higashi K, Morita M, Umeda T, Sato T: Studies of hypothyroidism in patients with high iodine intake

Dennoch ist die Erforschung des Enzymdefekts und damit verbundene gesundheitliche Beschwerden noch wissenschaftliches Neuland